Sickle Cell Disease — Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Citation(s)
A Phase 2 Multi-center, Randomized, Double-blind, Comparator-Controlled Dose Finding Study to Evaluate MP4CO for the Acute Treatment of Vaso-occlusive Crises in Subjects With Sickle Cell Disease